Trend — Injection, eptinezumab-jjmr, 1 mg (J3032) in Medicare, the United States
Trend · J3032 · National · CY2024
Trend: Growing
Twelve-year services series · J3032 · the United Statesincluded in Explore
The full twelve-year services and payments series for this market — per-year values, with the FFS-enrollment denominator beside each.
Compound growth · endpointsincluded in Explore
The compound annual growth for J3032 in the United States — endpoints exclude the introduction year; an Exclude 2020–21 view drops the pandemic years too.